| Date | Time | Source | Headline | Symbol | Company |
| 04/15/2005 | 10:00AM | PR Newswire (US) | Campral(R) is Safe and Well-Tolerated in Long-Term Treatment of Alcohol Dependence According to Results Presented at American So | NYSE:FRX | Forest Road Acquisition Corp |
| 04/11/2005 | 1:56PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2005 Fourth Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 04/06/2005 | 9:23AM | PR Newswire (US) | Forest Laboratories Issues Revised Estimate for Q4'05 Earnings Per Share | NYSE:FRX | Forest Road Acquisition Corp |
| 03/30/2005 | 5:10PM | PR Newswire (US) | Forest Laboratories, Inc. Receives Non-Approvable Letter for Social Anxiety Disorder Indication for Lexapro(R) | NYSE:FRX | Forest Road Acquisition Corp |
| 03/21/2005 | 9:24AM | PR Newswire (US) | MORNING UPDATE: Man Securities Inc. issues alerts for AIG, DRL, ADBE, SPLS, and FRX | NYSE:FRX | Forest Road Acquisition Corp |
| 03/21/2005 | 8:05AM | PR Newswire (US) | New COMBUNOX(TM) (Oxycodone HCl and Ibuprofen) Tablets (CII) Now Available for the Short-Term Treatment of Acute, Moderate to Se | NYSE:FRX | Forest Road Acquisition Corp |
| 03/16/2005 | 6:30PM | PR Newswire (US) | Shareholder Class Action Filed Against Forest Laboratories, Inc. by the Law Firm of Schiffrin & Barroway, LLP | NYSE:FRX | Forest Road Acquisition Corp |
| 03/14/2005 | 12:19PM | PR Newswire (US) | Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Forest Laboratories, Inc. | NYSE:FRX | Forest Road Acquisition Corp |
| 03/01/2005 | 4:10PM | PR Newswire (US) | Forest Laboratories, Inc. Receives Non-Approvable Letter for Panic Disorder Indication for Lexapro(R) | NYSE:FRX | Forest Road Acquisition Corp |
| 02/09/2005 | 8:05AM | PR Newswire (US) | Forest Laboratories Starts Confirmatory Study of Desmoteplase A Novel Investigational Treatment For Acute, Ischemic Stroke | NYSE:FRX | Forest Road Acquisition Corp |
| 02/08/2005 | 9:30AM | PR Newswire (US) | Forest Laboratories, Inc. Announces Launch of Clinical Trial Registry - http://www.forestclinicaltrials.com | NYSE:FRX | Forest Road Acquisition Corp |
| 01/18/2005 | 10:07AM | PR Newswire (US) | MORNING UPDATE: Man Securities Inc. issues alerts for DIS, BAC, MMM, STT, and FRX | NYSE:FRX | Forest Road Acquisition Corp |
| 01/18/2005 | 8:05AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Diluted Earnings Per Share of $0.70 for 3Q'05 | NYSE:FRX | Forest Road Acquisition Corp |
| 01/11/2005 | 8:01AM | PR Newswire (US) | First New Treatment for Alcoholism in Ten Years, Now Available Campral(R) (Acamprosate Calcium) Delayed-Release Tablets | NYSE:FRX | Forest Road Acquisition Corp |
| 01/07/2005 | 12:59PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2005 Third Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 01/04/2005 | 4:27PM | PR Newswire (US) | Forest Laboratories to Exceed Fiscal 2005 Third Quarter Mean Earnings Per Share Estimate | NYSE:FRX | Forest Road Acquisition Corp |
| 12/14/2004 | 8:05AM | PR Newswire (US) | Forest Laboratories Expands Share Repurchase Program | NYSE:FRX | Forest Road Acquisition Corp |
| 11/26/2004 | 4:21PM | PR Newswire (US) | FDA Approves Combunox(TM) (Oxycodone HCl and Ibuprofen) Tablets (CII) for the Short-Term Treatment Of Acute, Moderate to Severe | NYSE:FRX | Forest Road Acquisition Corp |
| 11/22/2004 | 4:10PM | PR Newswire (US) | Gedeon Richter and Forest Laboratories Announce Collaboration Agreement on Atypical Antipsychotic for Schizophrenia, Bipolar Man | NYSE:FRX | Forest Road Acquisition Corp |
| 11/15/2004 | 8:10AM | PR Newswire (US) | FDA Accepts Supplemental New Drug Application Filing to Expand Namenda's(R) Indication to Include Treatment of Mild Alzheimer's | NYSE:FRX | Forest Road Acquisition Corp |
| 11/02/2004 | 8:00AM | PR Newswire (US) | Forest Laboratories Updates Lercanidipine Development | NYSE:FRX | Forest Road Acquisition Corp |
| 11/01/2004 | 4:17PM | PR Newswire (US) | Forest Laboratories Revises FY2005 Earnings Guidance | NYSE:FRX | Forest Road Acquisition Corp |
| 10/19/2004 | 10:35AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for EMC, IBM, MCD, FRX, and MO | NYSE:FRX | Forest Road Acquisition Corp |
| 10/18/2004 | 9:07AM | PR Newswire (US) | Forest Laboratories Reports Earnings Per Share of $.79 for 2Q'05; Offers Updated Fiscal 2005 EPS Guidance | NYSE:FRX | Forest Road Acquisition Corp |
| 10/12/2004 | 5:15PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2005 Second Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 10/04/2004 | 5:30PM | PR Newswire (US) | Forest Laboratories to Exceed Fiscal 2005 Second and Third Quarter Mean Earnings Per Share Estimates | NYSE:FRX | Forest Road Acquisition Corp |
| 09/27/2004 | 9:50AM | PR Newswire (US) | Forest Laboratories Appoints Francis Perier as Senior Vice President - Finance and Chief Financial Officer | NYSE:FRX | Forest Road Acquisition Corp |
| 09/23/2004 | 9:00AM | PR Newswire (US) | Glenmark Pharmaceuticals and Forest Laboratories Announce Collaboration Agreement on PDE4 Inhibitor for Asthma and COPD | NYSE:FRX | Forest Road Acquisition Corp |
| 09/08/2004 | 3:10PM | PR Newswire (US) | /C O R R E C T I O N -- Forest Laboratories, Inc./ | NYSE:FRX | Forest Road Acquisition Corp |
| 09/07/2004 | 6:41PM | PR Newswire (US) | Forest Laboratories Announces Adoption of On-line Registry for Clinical Studies; Attorney General Agrees to Close Inquiry | NYSE:FRX | Forest Road Acquisition Corp |